Acne Therapeutics Market- Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence Pvt Ltd||商品編碼||391484|
|出版日期||內容資訊||英文 111 Pages
|痤瘡治療藥的全球市場:成長，趨勢，及預測(2019年∼2024年) Acne Therapeutics Market- Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年08月01日||內容資訊: 英文 111 Pages||
The key factors propelling the growth of the acne therapeutics market are increasing sedentary lifestyles and unhealthy lifestyles, the rise in disposable income of consumers, increasing awareness about upcoming trends in acne treatments, and high prevalence of acne, globally.
Topical is the Segment Under Administration that is Expected to Grow the Fastest
The utilization rate of topical medications for acne treatment is high, owing to the high availability of these acne products, with a high success rate and lesser side effects. These agents are directly applied to the skin and need to be used continuously for longer periods of time, from several weeks to months, to get effective results. There are topical antibiotics, retinoids, and other products, like azelaic acid and benzoyl peroxides, which are available in the form of gels, lotions, and creams.
Retinoids have been used for more than 25 years in the treatment of acne vulgaris. In recent years, new polyaromatic retinoids have been developed for the topical treatment of acne.
The most important topical antibiotics for acne treatment are tetracycline, erythromycin, and clindamycin.
Therefore, the preference for topical treatment is more, compared to the oral mode of therapeutic administration. These oral medications are recommended as systemic therapies after topical treatments fail to evoke a response.
Asia-Pacific Holds the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period
Asia-Pacific is expected to be the fastest-growing region, due to increasing sedentary lifestyles and unhealthy food habits. Prosperity and a faster pace of life have changed the Chinese eating habits. Eating too much with high amounts of fat and calories and exercising less have led to an increase in obesity and acne problems. However, Asia-Pacific is expected to register the highest CAGR, due to the increase in affordability, surge in healthcare expenditure, and rise in awareness about safe acne medication products.
The acne therapeutics market is highly competitive and consists of several major players and local players in the market. In the coming years, few other players are expected to enter the market. Some of the few major players include Allergan PLC, Valeant Pharmaceutical International Inc., Bayer AG, and Galderma (Nestle Skin Health), Roche, Teva, and Sun Pharma.